Paclitaxel
NDC 61703-015, PACLITAXEL, injection, solution, from Hospira, Inc..
- Product NDC
- 61703-015
- Status
- Listed
- Labeler
- Hospira, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076131
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61703-015 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PACLITAXEL6 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61703-015-04 | 61703001504 | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-015-04) / 5 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ea28753a-8631-460a-bfdc-b101eb8ac84aMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=61703-015
Use it
Look up 61703-015 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61703-015 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61703-015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.